cyproterone acetate has been researched along with Polycystic Ovary Syndrome in 162 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (8.64) | 18.7374 |
1990's | 27 (16.67) | 18.2507 |
2000's | 65 (40.12) | 29.6817 |
2010's | 48 (29.63) | 24.3611 |
2020's | 8 (4.94) | 2.80 |
Authors | Studies |
---|---|
Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
Chen, X; Feng, Y; Li, X; Liu, Y; Wang, Y; Yao, D; Zhang, F | 1 |
de Zegher, F; Díaz, M; Ibáñez, L | 1 |
Alesi, S; Forslund, M; Melin, J; Mousa, A; Pena, A; Piltonen, T; Romualdi, D; Tay, CT; Teede, H; Witchel, S | 1 |
Abtahi, H; Behboudi-Gandevani, S; Ramezani Tehrani, F; Saadat, N; Tohidi, M | 1 |
Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
Deng, Y; Ma, RL; Ma, X; Sun, AJ; Wang, YF; Xue, W; Zhu, SY | 1 |
Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G | 1 |
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
Aguilar, A; Kubba, A; Mueck, AO; Ruan, X | 1 |
Mueck, AO | 1 |
Amiri, M; Azizi, F; Carmina, E; Kabir, A; Nahidi, F; Ramezani Tehrani, F | 1 |
Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
Cao, Y; Liu, Z; Zhang, L; Zhao, D | 1 |
Cai, G; Du, J; Li, X; Li, Y; Mueck, AO; Ruan, X; Wang, H; Wang, L; Zhao, Y | 1 |
Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
Cao, Y; Chen, H; Liu, Z; Yu, X; Zhang, L; Zhao, D; Zhou, X | 1 |
Chen, H; Cheng, NCL; Lim, CED; Ng, RWC; Zhang, GS | 1 |
Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
Armutcu, F; Carlioglu, A; Gumus, II; Karakurt, F; Kasapoglu, B; Kaygusuz, I; Keskin, EA; Koca, C; Uysal, A; Uysal, S | 1 |
Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
Cahill, DJ; O'Brien, K | 1 |
Jin, CL; Wei, LX; Wu, ZC; Zhao, JP | 1 |
Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
Feng, W; Jia, YY; Shi, HR; Zhang, DY | 1 |
Catteau-Jonard, S; Dewailly, D; Gronier, H; Peigné, M; Plouvier, P; Robin, G | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Mao, XG; Tu, AS; Zhong, Y | 1 |
Feng, GM; Huang, W; Song, Y; Wang, QS; Wang, QY; Xiao, L | 1 |
Lim, CE; Wu, T; Xu, L; Zhang, J; Zhou, K | 1 |
Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
Li, J; Ren, J; Sun, W | 1 |
Cui, N; Feng, X; Hao, G; Wang, L; Xu, Y; Zhang, J; Zhao, Z | 1 |
Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Mendieta-Azcona, C | 1 |
Liao, H; Luo, WY; Sun, Y; Wang, CF; Zhang, D | 1 |
Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y | 1 |
Jing, Z; Liang-Zhi, X; Tai-Xiang, W; Ying, T; Yu-Jian, J | 1 |
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
Gaillard, RC; Gomez, F; Karrer-Voegeli, S; Meuwly, JY; Rey, F; Reymond, MJ | 1 |
Bilgir, F; Bilgir, O; Bozkaya, G; Kebapcilar, A; Kebapcilar, L; Sari, I; Taner, C; Yildiz, Y; Yuksel, A | 1 |
Alacacioglu, A; Bilgir, O; Kebapcilar, AG; Kebapcilar, L; Kozaci, DL; Sari, I; Taner, CE; Yildiz, Y; Yuksel, A | 1 |
Chen, HF; Chen, MJ; Chen, SU; Ho, HN; Kuo, JJ; Yang, WS; Yang, YS | 1 |
Goulis, DG; Makedos, A; Panidis, D; Papanikolaou, A | 1 |
Bilgir, O; Bozkaya, G; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE; Yildiz, Y | 1 |
Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
Bechlioulis, A; Kalantaridou, SN; Katsouras, CS; Kazakos, N; Kravariti, M; Michalis, LK; Naka, KK; Tsatsoulis, A | 1 |
Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
Aksoy, ON; Cakir, O; Colak, N; Nazli, Y | 1 |
Adonakis, G; Armeni, AK; Decavalas, G; Georgopoulos, NA; Karela, A; Markantes, G; Saltamavros, AD; Vervita, V | 1 |
Gui, SQ; Kuek, S; Wang, WJ | 1 |
Demirlenk, S; Karabulut, A; Sevket, O | 1 |
Bhattacharya, SM; Jha, A | 1 |
Dokras, A | 1 |
Koivunen, R; Martikainen, H; Morin-Papunen, L; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
de Vries, CS; Farmer, RD; Seaman, HE | 3 |
Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 2 |
Koyuncu, FM; Kuscu, NK; Onur, E; Var, A | 1 |
Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N | 1 |
Frank-Raue, K; Schulze, E | 1 |
Hedberg, P; Morin-Papunen, L; Puukka, M; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
Harma, M; Kilic, F; Nazligul, Y; Sabuncu, T | 1 |
Lin, JJ; Lin, WQ; Yang, HY; Ye, BL; Zhao, JZ | 1 |
Bendlová, B; Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
Herer, P; Luboshitzky, R; Nave, R; Shen-Orr, Z | 1 |
Herer, P; Luboshitzky, R; Shen-Orr, Z | 1 |
Chen, CY; Chen, PH; Hsieh, BC; Huang, LW; Huang, SC; Hwang, JL; Lin, YH; Seow, KM; Tsai, YL; Tzeng, CR; Wu, GJ | 1 |
Mitkov, M; Pekhlivanov, B; Terzieva, D | 1 |
Beigi, A; Sobhi, A; Zarrinkoub, F | 1 |
Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
Arteaga, E; Cárdenas, I; Hormaza, P; Oestreicher, E; Villaseca, P | 1 |
Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
Al-Inany, H | 2 |
Liu, Y; Lv, L; Sun, Y; Tan, K | 1 |
Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
Chen, LS; Zhou, JT | 1 |
Inal, MM; Taner, CE; Yildirim, Y | 1 |
Cagnacci, A; Paoletti, AM; Renzi, A; Tirelli, A; Volpe, A | 1 |
Creatsas, G; Deligeoroglou, E; Diamanti-Kandarakis, E; Koliopoulos, C; Mastorakos, G | 1 |
Cagnacci, A | 2 |
Foltyn, W; Kos-Kudła, B; Kudła, M; Mazur, B; Małecka-Mikosz, O; Ostrowska, Z | 1 |
Dvorakova, K; Hill, M; Starka, L; Vrbikova, J | 1 |
Corbould, A | 1 |
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
Atanasova, I; Genchev, G; Kamenov, Z; Khristov, V; Kolarov, G; Milcheva, B; Orbetsova, M; Shigarminova, R; Zakharieva, S | 1 |
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
Demirci, F; Gul, OB; Ozdemir, I; Somunkiran, A; Yucel, O | 1 |
Pijl, H; van Zuuren, EJ | 1 |
Franks, S; Glasier, A; Layton, A | 1 |
Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
Yildiz, BO | 1 |
Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG | 1 |
Antonelli, S; Barletta, C; Buzzetti, R; Dino, N; Giovannini, C; Raccamarich, I; Tarasco, A | 1 |
Baxendale, PM; Jacobs, HS; James, VH | 2 |
Costa, C; De Pedrini, P; Suraci, C | 1 |
Baranowska, B; Niewiadomska, A; Rozbicka, G | 1 |
Raj, SG; Talbert, LM | 1 |
Coney, P | 1 |
Rook, A | 1 |
Faredin, I; Julesz, J; László, FA; Tóth, I | 1 |
Oliver, I; Pienkowski, C; Pigeon, P; Rochiccioli, P; Tauber, MT | 1 |
Emperauger, B; Kuttenn, F | 1 |
Albrecht, AE; Hartmann, BW | 1 |
Falsetti, L; Pasinetti, E | 2 |
Aravantinos, D; Creatsas, G; Deligeoroglou, E; Hassan, E; Tolis, G | 1 |
Balint-Perić, LA; Prelević, GM; Puzigaća, Z | 1 |
Elstein, ME; Golland, IM | 1 |
Aglianò, A; Cianci, A; Ciotta, L; Giuffrida, G; Marletta, E; Palumbo, G | 1 |
Grunwald, K; Rabe, T; Runnebaum, B; Schlereth, G | 1 |
Azem, F; Bar-Am, A; Grisaru, D; Inbar, M; Lessing, JB; Oren, M | 1 |
Bártfai, G; Koloszár, S; Szöllösi, J | 1 |
Acién, P; Gutierrez, M; Mauri, M | 1 |
Franks, S | 1 |
Dramusic, V; Goh, VH; Rajan, U; Ratnam, SS; Wong, YC | 1 |
Diamanti-Kandarakis, E | 1 |
Rittmaster, RS | 1 |
Gjønnaess, H | 1 |
Kokaly, W; McKenna, TJ | 1 |
Cicinelli, E; D'Addario, V; De Pergola, G; De Salvia, MA; Schonauer, LM; Tartagni, M | 1 |
Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
Creatsas, G; Koliopoulos, C; Mastorakos, G | 2 |
Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
Kleinstein, J; Muenstermann, U | 1 |
Falsetti, L; Gambera, A; Tisi, G | 1 |
Armstrong, VL; Atkinson, AB; Bell, PM; Ennis, CN; Sheridan, B; Traub, AI; Wiggam, MI | 1 |
Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
Dai, Q; Tao, Y; Zhang, D | 1 |
Durmusoglu, F; Elter, K; Imir, G | 1 |
Balducci, R; Bozzola, M; Cisternino, M; Lorini, R; Pasquino, AM; Pucarelli, I; Segni, M; Severi, F | 1 |
Laatikainen, T; Seppälä, M; Stenman, UH; Suikkari, AM; Tiitinen, A | 1 |
de Rooy, HA; Ponjee, GA; Vader, HL | 1 |
Giagulli, VA; Giorgino, R; Vermeulen, A | 1 |
Eden, JA | 1 |
Falsetti, L; Galbignani, E | 1 |
Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
Balint-Perić, L; Prelević, GM; Puzigaća, Z; Würzburger, MI | 1 |
Bovicelli, L; Fabbri, R; Flamigni, C; Orsini, LF; Paradisi, R; Porcu, E; Saviotti, E; Venturoli, S | 1 |
Brailly, S; Couzinet, B; Le Strat, N; Schaison, G | 1 |
Cabero-Roura, A; Calaf-Alsina, J; Esteban-Altirriba, J; Lenti-Paoli, O; Mora-Brugues, J; Rodriguez-Espinosa, J | 1 |
Couzinet, B; Schaison, G | 1 |
19 review(s) available for cyproterone acetate and Polycystic Ovary Syndrome
Article | Year |
---|---|
Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2023 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 2017 |
Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins.
Topics: Blood Glucose; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin; Lipid Metabolism; Metabolome; Polycystic Ovary Syndrome; Progestins; Time Factors | 2017 |
Acupuncture for polycystic ovarian syndrome.
Topics: Abortion, Spontaneous; Acupuncture Therapy; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Menstruation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic | 2019 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Topics: Adult; Clomiphene; Cyproterone Acetate; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Infertility; Laparoscopy; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Suction | 2016 |
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome | 2017 |
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Topics: Algorithms; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome | 2008 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
[Hirsutism].
Topics: Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Female; Hirsutism; Humans; Obesity; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome; Weight Loss | 2007 |
Polycystic ovarian disease.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Chorionic Gonadotropin; Cimetidine; Clomiphene; Contraceptive Agents, Female; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone | 1984 |
Polycystic ovarian disease: current concepts of pathophysiology and therapy.
Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Glands; Androgen Antagonists; Androstenedione; Animals; Cimetidine; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone; Testosterone | 1984 |
Aspects of cutaneous androgen-dependent syndromes.
Topics: Acne Vulgaris; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Alopecia; Androgens; Cyproterone; Cyproterone Acetate; Female; Hair; Hirsutism; Humans; Male; Polycystic Ovary Syndrome; Racial Groups; Sex Characteristics; Stress, Psychological; Syndrome | 1980 |
[Polycystic ovarian dystrophies. Diagnostic criteria and treatment].
Topics: Clomiphene; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Danazol; Endocrine System Diseases; Female; Humans; Polycystic Ovary Syndrome | 1995 |
[Current therapy of polycystic ovary].
Topics: Combined Modality Therapy; Cyproterone Acetate; Female; Gonadal Steroid Hormones; Humans; Infertility, Female; Polycystic Ovary Syndrome; Progesterone Congeners | 1995 |
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Topics: Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Humans; Polycystic Ovary Syndrome | 1998 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
73 trial(s) available for cyproterone acetate and Polycystic Ovary Syndrome
Article | Year |
---|---|
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments.
Topics: Adolescent; Cyproterone Acetate; Diabetes Mellitus, Type 2; Female; Follistatin; Humans; Hypoglycemic Agents; Insulin; Metformin; Pioglitazone; Polycystic Ovary Syndrome | 2023 |
Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin; Insulin Resistance; Phlebotomy; Polycystic Ovary Syndrome; Testosterone; Triglycerides; Young Adult | 2019 |
Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2020 |
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult | 2021 |
[
Topics: Acupuncture Points; Acupuncture Therapy; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovary; Pilot Projects; Polycystic Ovary Syndrome | 2017 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
The efficacy of Tung's acupuncture for sex hormones in polycystic ovary syndrome: A randomized controlled trial.
Topics: Acupuncture; Acupuncture Therapy; Adult; Body Mass Index; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Polycystic Ovary Syndrome | 2019 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
[Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome].
Topics: Acupuncture Points; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Electroacupuncture; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Young Adult | 2014 |
Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
Topics: Adolescent; Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin Resistance; Life Style; Lipids; Metformin; Polycystic Ovary Syndrome; Prospective Studies | 2016 |
Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Arteries; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Tunica Intima; Young Adult | 2009 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).
Topics: Adult; Antineoplastic Agents; Cell Adhesion Molecules; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Young Adult | 2009 |
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
Topics: Adolescent; Adult; CD40 Antigens; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2010 |
Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
Topics: Adult; Androgen Antagonists; Body Mass Index; CD40 Antigens; Contraceptives, Oral; Cyproterone Acetate; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Young Adult | 2011 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Vasodilation; Young Adult | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Topics: Adolescent; Adult; Blood Viscosity; Body Mass Index; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrinogen; Humans; Polycystic Ovary Syndrome; Triglycerides; Young Adult | 2011 |
Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Metformin; Phytotherapy; Polycystic Ovary Syndrome; Young Adult | 2011 |
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Blood Glucose; Blood Pressure; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Female; Follow-Up Studies; Hirsutism; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2012 |
Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Energy Metabolism; Estradiol Congeners; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Hormones; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipids; Metformin; Oxidation-Reduction; Polycystic Ovary Syndrome | 2003 |
Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Leptin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Steroids | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Sebum | 2003 |
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Progesterone Congeners | 2003 |
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Appetite Depressants; Blood Pressure; Body Constitution; Body Weight; Cyclobutanes; Cyproterone Acetate; Diastole; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2003 |
[Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Topics: Adult; Antineoplastic Agents; Cholesterol, HDL; Cyproterone Acetate; Dehydroepiandrosterone; Drug Therapy, Combination; Female; Gonadotropins; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2003 |
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Blood Glucose; Contraceptive Agents; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Polycystic Ovary Syndrome | 2004 |
Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormones; Humans; Incidence; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pilot Projects; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Premedication | 2004 |
[Combined use of metformin and Diane35 in polycystic ovary syndrome].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome | 2004 |
Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies | 2004 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.
Topics: Administration, Oral; Adult; Androgens; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyproterone Acetate; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Treatment Outcome; Triglycerides | 2004 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome | 2005 |
Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome | 2005 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
[Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Phytotherapy; Polycystic Ovary Syndrome; Tablets | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Vitamin B 12 | 2006 |
Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.
Topics: Adolescent; Androgen Antagonists; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Fasting; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Polycystic Ovary Syndrome | 2006 |
Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
Topics: Adult; Androgen Antagonists; Androgens; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Ghrelin; Humans; Peptide Hormones; Polycystic Ovary Syndrome; Testosterone | 2006 |
Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
Topics: Adult; Androgens; Body Weight; Contraception; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome; Weight Gain | 2006 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Homocysteine; Humans; Lipids; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2008 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid | 2008 |
[Analysis of the results of treatment of idiopathic hirsutism and hirsutism in patients with polycystic ovary syndrome with androcur (cyproterone acetate)].
Topics: Adult; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Female; Follow-Up Studies; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1983 |
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipid Metabolism; Lipoproteins; Polycystic Ovary Syndrome; Pregnancy; Testosterone; Triglycerides | 1995 |
Treatment of polycystic ovarian disease during adolescence with ethinylestradiol/cyproterone acetate versus a D-Tr-6-LHRH analog.
Topics: Adolescent; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Dinoprostone; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triptorelin Pamoate | 1993 |
Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Injections, Intramuscular; Leuprolide; Luteinizing Hormone; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin | 1994 |
Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Tolerance; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Ultrasonography | 1993 |
[Ovulation induction with adjuvant antiandrogen treatment in Stein-Leventhal syndrome].
Topics: Adult; Androgen Antagonists; Anovulation; Cyproterone Acetate; Dexamethasone; Female; Humans; Hyperandrogenism; Infertility, Female; Mineralocorticoid Receptor Antagonists; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Spironolactone | 1996 |
Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hype
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Polycystic Ovary Syndrome; Treatment Outcome; Triptorelin Pamoate | 1997 |
Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Goserelin; Hirsutism; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome | 1998 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Treatment Outcome | 2000 |
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
Topics: Adolescent; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome | 2000 |
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome | 2000 |
Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
Topics: Adult; Androgen Antagonists; Chorionic Gonadotropin; Clomiphene; Cyproterone Acetate; Drug Combinations; Electrocoagulation; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Laparoscopy; Lasers; Leuprolide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Recombinant Proteins | 2000 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Severity of Illness Index; Triglycerides | 2002 |
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.
Topics: Adolescent; Adult; Androstenedione; Body Constitution; Body Mass Index; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin | 2002 |
Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1986 |
Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.
Topics: Adult; Androgens; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Random Allocation; Triptorelin Pamoate | 1987 |
70 other study(ies) available for cyproterone acetate and Polycystic Ovary Syndrome
Article | Year |
---|---|
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
Topics: Androgen Antagonists; Animals; Apoptosis; Autophagy; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Endometrial Neoplasms; Ethinyl Estradiol; Female; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin-Like Growth Factor I; Metformin; Mice; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 2017 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
Topics: Adult; Androgen Antagonists; Birth Weight; China; Clomiphene; Cyproterone Acetate; Diabetes, Gestational; Drug Combinations; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Premature Birth; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Time-to-Pregnancy; Treatment Outcome; Young Adult | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Androgen Antagonists; Aryldialkylphosphatase; Body Mass Index; Carboxylic Ester Hydrolases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Metformin; Phospholipase A2 Inhibitors; Platelet Activating Factor; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Treatment Outcome | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Polycystic ovary syndrome (PCOS): metformin.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Weight Reduction Programs | 2015 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Outcome Assessment, Health Care; Polycystic Ovary Syndrome; Young Adult | 2016 |
Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Mullerian Hormone; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Hyperandrogenism; Longitudinal Studies; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2016 |
[Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility].
Topics: Antioxidants; Apoprotein(a); Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oxidative Stress; Polycystic Ovary Syndrome | 2016 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
Topics: Adult; Amidohydrolases; Androgen Antagonists; Arachidonic Acids; Cyproterone Acetate; Drug Combinations; Endocannabinoids; Endometrium; Ethinyl Estradiol; Female; Glycerides; Humans; Infertility, Female; Metformin; Polycystic Ovary Syndrome; Polyunsaturated Alkamides; Receptors, Cannabinoid; Young Adult | 2017 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
[The effects of oxidative stress to PCOS].
Topics: Androgen Antagonists; Antioxidants; Ascorbic Acid; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Polycystic Ovary Syndrome; Superoxide Dismutase; Vitamin E | 2008 |
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult | 2008 |
Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Alopecia; Androgens; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Hirsutism; Humans; Oligomenorrhea; Polycystic Ovary Syndrome; Risk Factors; Saliva; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography; Young Adult | 2009 |
Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Follistatin; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies | 2010 |
Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Homocysteine; Humans; Linear Models; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric | 2010 |
Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polycystic Ovary Syndrome; Thyroid Gland; Venous Thrombosis | 2011 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |
In search of the best combined oral contraceptive for treatment of polycystic ovary syndrome.
Topics: Androstenes; Cyproterone Acetate; Desogestrel; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 2012 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Odds Ratio; Polycystic Ovary Syndrome; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
[Hirsutism].
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Cyproterone Acetate; Dexamethasone; Diagnosis, Differential; Female; Glucocorticoids; Hirsutism; Humans; Hydrocortisone; Hyperandrogenism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Pregnancy; Risk Factors | 2003 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Melatonin; Polycystic Ovary Syndrome | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Polycystic Ovary Syndrome; United Kingdom; Venous Thrombosis | 2004 |
Oral contraceptives and insulin sensitivity.
Topics: Adolescent; Androgen Antagonists; Blood Glucose; Carbohydrate Metabolism; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Fasting; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Polycystic Ovary Syndrome | 2006 |
Oral contraceptives and insulin sensitivity.
Topics: Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Female; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2006 |
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.
Topics: Adipocytes; Adult; Analysis of Variance; Biological Transport; Cell Differentiation; Cells, Cultured; Cyproterone Acetate; Female; Flutamide; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Phosphoproteins; Phosphorylation; Polycystic Ovary Syndrome; Protein Kinase C; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Subcutaneous Fat; Testosterone | 2007 |
[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
Topics: Androgen Antagonists; Blood Glucose; Body Composition; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation Disturbances; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Venous Thromboembolism | 2008 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |
Assessment, diagnosis and treatment of a patient with hirsutism.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Ultrasonography | 2008 |
[A case of Stein-Leventhal syndrome].
Topics: Adult; Clomiphene; Cyproterone; Cyproterone Acetate; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1984 |
Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women.
Topics: Adolescent; Adult; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva; Testosterone | 1982 |
[Therapy of female hirsutism: current status and new findings].
Topics: Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Bromocriptine; Cimetidine; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Progesterone Congeners; Spironolactone; Thyronines; Time Factors | 1983 |
Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Radioimmunoassay; Saliva | 1983 |
Cyproterone acetate treatment of females with hyperandrogenism.
Topics: 17-Ketosteroids; Acne Vulgaris; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Alanine Transaminase; Aspartate Aminotransferases; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Hydrocortisone; Polycystic Ovary Syndrome; Testosterone | 1981 |
[Precocious puberty and polycystic ovarian syndrome: apropos of 13 cases].
Topics: Androgen Antagonists; Child; Cyproterone Acetate; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Puberty, Precocious; Testosterone | 1995 |
Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1993 |
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.
Topics: Adult; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Leuprolide; Polycystic Ovary Syndrome | 1996 |
[Serum hormones before and during therapy with cyproterone acetate and spironolactone in patients with androgenization].
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonadal Steroid Hormones; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone | 1994 |
A case of severe hyperandrogenism, acanthosis nigricans and over diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management.
Topics: Acanthosis Nigricans; Adult; Amenorrhea; Cyproterone Acetate; Diabetes Mellitus, Type 2; Female; Hirsutism; Humans; Hyperandrogenism; Magnetic Resonance Imaging; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1996 |
Polycystic ovary syndrome.
Topics: Adolescent; Androgen Antagonists; Cyproterone Acetate; Female; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1997 |
Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Topics: Adolescent; Adult; Androgen Antagonists; Body Weight; Child; Cyproterone Acetate; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Singapore; Testosterone; Ultrasonography | 1997 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
Topics: Adult; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Polycystic Ovary Syndrome; Recurrence; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 2000 |
Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adult; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Ovary; Polycystic Ovary Syndrome; Time Factors; Ultrasonography | 2001 |
Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
Topics: Adult; Androgens; Blood Glucose; Case-Control Studies; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Secretion; Luteinizing Hormone; Polycystic Ovary Syndrome; Progesterone Congeners; Secretory Rate; Sex Hormone-Binding Globulin; Testosterone | 2001 |
[Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
Topics: Adult; Androgen Antagonists; Clomiphene; Cyproterone Acetate; Female; Fertility Agents, Female; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome | 1999 |
Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate.
Topics: Body Height; Child, Preschool; Cyproterone Acetate; Female; Follow-Up Studies; Gonads; Humans; Menarche; Polycystic Ovary Syndrome; Puberty, Precocious; Sexual Maturation | 1992 |
Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Luteinizing Hormone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1991 |
Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1991 |
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1991 |
The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome | 1991 |
Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Androstenedione; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Liver; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1989 |
Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Ovary; Ovulation; Polycystic Ovary Syndrome; Time Factors; Ultrasonography; Uterus | 1985 |
Effects of a cyproterone-containing oral contraceptive on hormonal levels in polycystic ovarian disease.
Topics: Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Pituitary Hormones; Polycystic Ovary Syndrome | 1987 |